Evidence-Based Oncology Project - 31/08/11
Doi : 10.1016/S1055-3207(03)00072-3
Ari D Brooks, MD a, b, ⁎, Isabel Sulimanoff, MLS b
a Department of Surgery, New York, New York USA
b Memorial Sloan-Kettering Cancer Center, New York, New York USA
Address reprint requests to, Ari D. Brooks, MD, Department of Surgery, MCP Hahnemann University Medical School, 245 North 15th Street, MS #413, Philadelphia, PA 19102 USARésumé |
This article gives a brief overview of what can be gained from randomized clinical trials and the problems that are faced when examining the results of these trials. It also discusses the two essential elements driving the evidence-based oncology project, the first being the growth of MEDLINE and similar databases of medical publications, and the second being the concept of levels of evidence and quality.
Le texte complet de cet article est disponible en PDF.Plan
© 2002
W.B. Saunders Company. Tous droits réservés.
Vol 11 - N° 1
P. 3-10 - janvier 2002 Retour au numéro
Article précédent
- Randomized Clinical Trials in Oncology Commentary
- Murray F. Brennan
- Randomized Clinical Trials in Soft Tissue Sarcoma
- Martin D. McCarter, David P. Jaques, Murray F. Brennan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?